Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
In the realm of pharmaceutical research and development, specific chemical building blocks are indispensable for creating targeted therapies. Among these, 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine (CAS: 3680-69-1) stands out as a pivotal intermediate, particularly for its role in the synthesis of kinase inhibitors. Kinase inhibitors are a cornerstone in modern medicine, revolutionizing the treatment of diseases ranging from cancer and inflammatory conditions to autoimmune disorders.
Understanding Kinase Inhibitors and Their Importance
Kinases are enzymes that play critical roles in cellular signaling pathways. Aberrant kinase activity is often implicated in the pathogenesis of various diseases. Kinase inhibitors work by blocking the activity of these enzymes, thereby disrupting disease-promoting signaling cascades. The development of selective and potent kinase inhibitors has led to significant therapeutic advancements.
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine as a Scaffold
The pyrrolo[2,3-d]pyrimidine core, provided by 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine, is a privileged structure in medicinal chemistry. This bicyclic heterocyclic system is frequently found in compounds designed to inhibit various kinases, including Janus kinases (JAKs), Bruton's tyrosine kinase (BTK), and others. Its structural features allow for strategic modifications to achieve desired binding affinities and selectivity profiles for specific kinase targets.
As a leading manufacturer and supplier of this key intermediate, we enable researchers and pharmaceutical companies to access this essential component for their drug discovery programs. The ability to buy 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine with high purity ensures that the complex synthesis of these advanced inhibitors can proceed efficiently and reliably.
Applications in Drug Development
One of the most prominent applications of 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine is in the synthesis of Tofacitinib. Tofacitinib is an oral JAK inhibitor approved for treating conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. The efficient synthesis of Tofacitinib relies heavily on the availability of high-quality 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine from reliable manufacturers. Our commitment as a supplier in China ensures that such critical intermediates are accessible for global pharmaceutical needs.
For companies looking to develop next-generation kinase inhibitors, sourcing this intermediate is a strategic first step. We provide not just the chemical itself but also the assurance of quality and consistent supply that is crucial for research and scale-up manufacturing. We invite you to contact us to inquire about pricing and availability for your specific projects.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
